Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages

Aleksi Lahti, Ulla Jalonen, Hannu Kankaanranta and Eeva Moilanen
Molecular Pharmacology August 2003, 64 (2) 308-315; DOI: https://doi.org/10.1124/mol.64.2.308
Aleksi Lahti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulla Jalonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannu Kankaanranta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eeva Moilanen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 64 no. 2 308-315
DOI 
https://doi.org/10.1124/mol.64.2.308
PubMed 
12869635

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received January 2, 2003
  • Accepted April 16, 2003
  • Published online July 17, 2003.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Aleksi Lahti,
  2. Ulla Jalonen,
  3. Hannu Kankaanranta and
  4. Eeva Moilanen
  1. The Immunopharmacological Research Group, University of Tampere Medical School and Tampere University Hospital, Tampere, Finland
  1. Address correspondence to:
    Dr. Eeva Moilanen, Medical School, FIN-33014 University of Tampere, Finland. E-mail: eeva.moilanen{at}uta.fi
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2003 to May 2022

AbstractFullPdf
Jul 20032811468
Aug 2003279952
Sep 2003239649
Oct 2003227946
Nov 2003286345
Dec 2003185326
Jan 2004245925
Feb 2004154515
Mar 2004204119
Apr 2004112417
May 2004175718
Jun 2004276638
Jul 2004195719
Aug 2004164525
Sep 2004146337
Oct 2004147533
Nov 2004144026
Dec 2004144011
Jan 2005244029
Feb 2005114614
Mar 2005114920
Apr 200543725
May 2005123620
Jun 200574814
Jul 2005163112
Aug 2005123310
Sep 200574020
Oct 20056359
Nov 200593011
Dec 20058338
Jan 20068248
Feb 200694116
Mar 200683418
Apr 200663129
May 200610169
Jun 20064153
Jul 200671610
Aug 200651911
Sep 200615115
Oct 200631812
Nov 20061106
Dec 20062117
Jan 200742010
Feb 20071812
Mar 200741313
Apr 20077219
May 20075119
Jun 200721614
Jul 200761818
Aug 200741511
Sep 2007353
Oct 200772119
Nov 20073128
Dec 2007697
Jan 2008355
Feb 20088410
Mar 2008151813
Apr 200811103
May 200818107
Jun 200814107
Jul 200819217
Aug 200882143
Sep 200839138
Oct 20082494
Nov 20081097
Dec 2008585
Jan 200912184
Feb 200913155
Mar 200926165
Apr 20092787
May 20094108
Jun 20098114
Jul 20097113
Aug 20096127
Sep 20099115
Oct 200923411
Nov 20091386
Dec 20092069
Jan 20101357
Feb 2010646
Mar 2010767
Apr 2010696
May 20106146
Jun 201010148
Jul 20101279
Aug 201013189
Sep 201013910
Oct 20108113
Nov 201015258
Dec 201014105
Jan 20117144
Feb 201132196
Mar 201110167
Apr 2011867
May 201151417
Jun 2011998
Jul 20111167
Aug 2011838
Sep 20111753
Oct 2011695
Nov 2011141114
Dec 2011101415
Jan 2012399
Feb 20125119
Mar 201211168
Apr 20128159
May 201210106
Jun 20129135
Jul 2012141814
Aug 20127123
Sep 2012101411
Oct 201211108
Nov 2012111913
Dec 201214107
Jan 201313205
Feb 20131287
Mar 201312126
Apr 201313119
May 20133144
Jun 20133615
Jul 20136614
Aug 2013677
Sep 2013145
Oct 2013193
Nov 2013874
Dec 2013183
Jan 20141567
Feb 2014437
Mar 2014795
Apr 20147157
May 20144295
Jun 2014768
Jul 20148102
Aug 2014403
Sep 2014462
Oct 201410610
Nov 20141086
Dec 20141211
Jan 20152103
Feb 2015742
Mar 2015613
Apr 2015212
May 2015585
Jun 2015833
Jul 20151577
Aug 2015463
Sep 2015463
Oct 20152184
Nov 2015724
Dec 2015944
Jan 20161265
Feb 20161987
Mar 20165411
Apr 20167910
May 2016854
Jun 2016434
Jul 20162107
Aug 2016681
Sep 20163150
Oct 20167144
Nov 2016093
Dec 2016172
Jan 2017080
Feb 20170114
Mar 2017195
Apr 2017090
May 20171120
Jun 20170100
Jul 20171183
Aug 20170153
Sep 2017093
Oct 20172171
Nov 20170191
Dec 20170140
Jan 20180100
Feb 20181104
Mar 2018072
Apr 20180217
May 20180120
Jun 20180124
Jul 20180101
Aug 20180101
Sep 2018040
Oct 2018272
Nov 20180282
Dec 20182741
Jan 20193310
Feb 20194500
Mar 20191400
Apr 20191500
May 20191000
Jun 20191004
Jul 20191110
Aug 20191200
Sep 2019800
Oct 20191713
Nov 20192011
Dec 20191031
Jan 20201531
Feb 20201100
Mar 2020500
Apr 2020500
May 2020810
Jun 2020510
Jul 2020800
Aug 2020101
Sep 2020520
Oct 2020910
Nov 2020600
Dec 20201411
Jan 20211720
Feb 20211611
Mar 20211310
Apr 20211010
May 2021521
Jun 20211520
Jul 20212010
Aug 20211210
Sep 2021921
Oct 20211510
Nov 20211121
Dec 20211210
Jan 20221210
Feb 2022911
Mar 2022110
Apr 2022910
May 2022300

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 64 (2)
Molecular Pharmacology
Vol. 64, Issue 2
1 Aug 2003
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages

Aleksi Lahti, Ulla Jalonen, Hannu Kankaanranta and Eeva Moilanen
Molecular Pharmacology August 1, 2003, 64 (2) 308-315; DOI: https://doi.org/10.1124/mol.64.2.308

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

c-Jun NH2-Terminal Kinase Inhibitor Anthra(1,9-cd)pyrazol-6(2H)-one Reduces Inducible Nitric-Oxide Synthase Expression by Destabilizing mRNA in Activated Macrophages

Aleksi Lahti, Ulla Jalonen, Hannu Kankaanranta and Eeva Moilanen
Molecular Pharmacology August 1, 2003, 64 (2) 308-315; DOI: https://doi.org/10.1124/mol.64.2.308
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics